ESTRO 35 2016 S755 ________________________________________________________________________________ system (OMS), thus allowing individual patient dose records to be monitored and radiotherapy imaging dose reference levels (DRLs) to be developed.
Material and Methods: DICOM query/retrieve is used to index and fetch CT dose report objects known to the PACS. Protocol information, patient details, CTDI and DLP are extracted. A script runs against the OMS and extracts CBCT activity information, including exposure settings and scan length. All information is converted into a standard format and stored in a data warehouse structured to make data exploration straightforward using readily available reporting and data mining tools. Data can be plotted and tabulated as a function of scanner, linac, operator, day of week, etc. Authorised operators can drill down to the patient, study and series level to understand the pre-treatment and linac imaging performed on individual patients and review the overall imaging dose record. Data can also be presented anonymised or pseudonymised for research, development and audit purposes. Table 1 shows data volumes and extract timings for a large centre (8 linacs with CBCT). The processing burden to update the data warehouse on a nightly basis is negligible.
Results:
Radiotherapy pre-treatment exposures were consistent with the equivalent diagnostic investigations and both were in line with local and national DRLs. There was clear evidence that when more advanced and automated linac imaging equipment is available more CBCTs are acquired (linacs VT1 and VT3 in Figure 1 ). Optimisation strategies can be studied by reviewing dose information alongside image quality and clinical decision making (see Figure 2 , where dose differs between linacs and was deliberately increased when imaging a large patient).
It was found that ARIA does not always correctly record CBCT exposure information, although if linac imaging is protocol driven there is a unique relationship between recorded values and protocol selected. Also, body site information may be coded differently between CT scanners. Data warehouse mapping tables were employed to identify the actual CBCT protocols utilised and standardise site descriptions.
Conclusion:
An automated data warehouse empowers professionals who are not IT experts to ask clinically relevant questions of a rich data source of imaging performance and dose information.
EP-1622
Cyberknife® M6TM: peripheral dose evaluation in brain treatments N. Delaby Purpose or Objective: Radiosurgery (SRS) and stereotactic radiotherapy (SRT) are known to deliver very high doses per fraction. The corresponding peripheral dose can be a limiting parameter which potentially generates late toxicities. The purpose of this study was to evaluate peripheral dose delivered to healthy tissues such as thyroid and gonads for brain SRS/SRT treatments performed with a Cyberknife® M6TM system.
Material and Methods:
Measurements were performed on a Cyberknife® M6TM (Accuray) equipped with fixed and IrisTM collimator systems. Doses were measured with GR200A (LiF:Mg, Cu, P) thermoluminescent dosimeters (TLD). Each TLD was individually calibrated in a 6 MV beam. TLD readings were performed with a PCL3 automatic reader (FIMEL). Firstly, in-vitro measurements were carried out in an anthropomorphic phantom (CIRS ATOM 701-c) for different typical brain treatment plans using different beam apertures (5 mm to 60 mm). Peripheral doses were measured at 24 points distributed from thyroid to gonads on the median line of the phantom (between 15 cm and 82.5 cm from the PTV center). Secondly, in-vivo measurements were performed on 30 patients, in 4 points representative of thyroid, breast, umbilicus and gonads. The number of monitor units (MU) used for treatment plans ranged from 5499 MU to 28900 MU with a mean value of 13737 MU, delivered in 1 to 3 fractions. Results were compared with peripheral dose published for previous Cyberknife® versions. Treatment plans were calculated with Multiplan v5.1.2 (Accuray). Peripheral dose were reported in cGy as percentage of the number of delivered Monitor Units (% of MU). 
Results
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ESTRO 35 2016 _____________________________________________________________________________________________________ Conclusion: Peripheral dose for the Cyberknife® M6TM version is lower than previous Cyberknife® versions. Nevertheless, for a brain treatment the dose can reach 10 cGy in the thyroid and can exceed 7 cGy in gonads; it should be evaluated for every localization. Peripheral dose will depend on number of monitor units, beam aperture size and collimator system. These parameters should be optimized during treatment planning to limit peripheral dose as lower as possible. 
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EP-1623 Correlation of organ doses and IEC and AAPM methods for cone beam computed tomography (CBCT)
A. Abuhaimed Purpose or Objective: Several dosimetric methods were proposed to overcome limitations of the standard dose index used for CT dosimetry (CTDI100) with cone beam computed tomography (CBCT). Two of these methods were proposed by IEC and AAPM. The aim of this project was to investigate the correlation between organ doses (ODs) resulting from head, thorax, and pelvic CBCT scans and the IEC and AAPM methods.
Material and Methods:
The IEC method (CTDIIEC) is based on measuring CTDI100 using a reference beam and the application of a correction factor based on free-in-air CTDI measurements, while the AAPM method f(0) is based on measuring cumulative dose using a small ionization chamber at the middle of an infinitely long phantom ≥450 mm. CTDIIEC was evaluated within CTDI head and body phantoms, whereas f(0) was assessed within 450 mm long CTDI phantoms. CTDIIEC and f(0) were measured at the centre and periphery of the phantoms using head, thorax, and pelvic scanning protocols used in the clinic. ODs were evaluated in terms of absorbed dose to organs and tissues using Monte Carlo simulations on the ICRP-110 adult male and female reference computational phantoms. BEAMnrc and DOSXYZnrc user codes were utilized to simulate On-Board Imager (OBI) system mounted on a TrueBeam linac and to assess ODs using the same scanning protocols used for CTDIIEC and f(0). The correlation was studied as the difference between weighed values (2/3 periphery:1/3 centre) of CTDIIEC,w and f(0)w and ODs. The correlation was investigated for organs, which have higher weights of effective dose.
Results: For head scan, CTDIIEC,w were smaller than doses to bone marrow, brain, and salivary gland by 4-55% for male and by 16-84% for female. f(0)w was also smaller than doses to bone marrow and salivary gland by 7-26% and 49-50% for male and female, respectively, but was larger than brain dose by 15% and 5%, respectively. For thorax scan, doses to bone marrow, lung, breast, and oesophagus were underestimated by CTDIIEC,w and f(0)w by 61-100% and 35-58% for male and by 108-161% and 64-106% for female, respectively. However, CTDIIEC,w and f(0)w overestimated doses to stomach and thyroid by 10-34% and 29-45% for male and by 13-28% and 31-43% for female, respectively. For pelvic scan, CTDIIEC,w and f(0)w were smaller than doses to bone marrow and urinary bladder by 91-173% and 51-116%, respectively, but were larger than colon and gonads doses by 30-78% and 44-82%, respectively, for male. For female, however, doses to all the organs were underestimated by CTDIIEC,w and f(0)w by 76-204% and 40-141%, respectively.
Conclusion:
The correlations between CTDIIEC,w and f(0)w and ODs were comparable to the majority of organs. In general, however, f(0)w gave a better estimation for ODs compared to CTDIIEC,w for the scanning protocols studied.
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Influence of organ motion on radiation-induced secondary cancer for VMAT and IMPT of prostate cancer C. Stokkevåg
